Pomelo Care, a pioneering virtual medical practice dedicated to enhancing maternal and newborn health outcomes, has secured $46 million in Series B financing. Led by existing investors First Round Capital and Andreessen Horowitz (a16z) Bio + Health, this funding round will empower Pomelo to scale its innovative care model nationwide, focusing on reducing maternal morbidity and improving access to evidence-based healthcare.
In a healthcare landscape marked by persistent maternal health crises and significant disparities, Pomelo Care stands out for its data-driven approach and proven results. The company leverages advanced analytics to proactively identify and address individual risk factors, offering virtual pregnancy, postpartum, and infant care that significantly reduces risks associated with maternal complications.
“With this latest round of funding, Pomelo Care is poised to make substantial strides in revolutionizing maternal healthcare,” said Marta Bralic Kerns, Founder & CEO of Pomelo Care. “Our model not only enhances clinical outcomes but also increases accessibility to high-quality care, particularly in underserved communities.”
The Series B financing brings Pomelo’s total funding to $79 million, underscoring investor confidence in the company’s ability to drive meaningful change. The investment will support Pomelo’s expansion of partnerships with healthcare payors nationwide, aiming to mitigate the critical gaps in postpartum care and reduce avoidable healthcare costs.
“Pomelo Care exemplifies the intersection of healthcare innovation and impactful outcomes,” remarked Vineeta Agarwala, MD, PhD, General Partner at a16z Bio + Health and Pomelo board member. “By scaling our virtual care solutions to cover over 3 million lives, we are positioned to deliver personalized, technology-driven care that addresses the unique needs of expecting mothers and newborns.”
Pomelo Care’s commitment to improving maternal health is further underscored by its recent publication of peer-reviewed data, demonstrating significant enhancements in clinical outcomes. The research highlighted Pomelo’s ability to increase the uptake of preventive strategies such as aspirin prophylaxis for preeclampsia and mental health screenings, resulting in marked reductions in maternal complications and emergency room visits.
